Last Updated: September 24, 2026

Claims for Patent: 11,083,758

✉ Email this page to a colleague

Summary for Patent: 11,083,758

Title:	Placental membrane preparations and methods of making and using same for regenerating cartilage and spinal intervertebral discs
Abstract:	A method for treating cartilage defects including providing a placental membrane preparation that includes ground or minced placental membranes and optionally, a ground or minced cartilage and/or biocompatible glue, and introducing the preparation to a cartilage defect within a skeletal joint. The cartilage defect may include a hyaline cartilage defect, such as a chondral defect, or meniscal defect. The treatment may be provided in combination with other treatments such as marrow stimulation treatments and surgical repair treatments using sutures or other fixation techniques. The preparation promotes the regeneration of cartilage within the skeletal joint.
Inventor(s):	Stephen LUCEY, Samuel K. Tabet, II Jack Farr, John J. Anderson, Katie C. Mowry, Gregory J. Yager, Howard P. Walthall, JR.
Assignee:	Prime Merger Sub LLC
Application Number:	US14/712,156

Details for Patent 11,083,758

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Csl Behring Llc	ZEMAIRA	alpha-1-proteinase inhibitor (human)	For Injection	125078	8-Jul-03	⤷ Start Trial	2035-05-14
Csl Behring Llc	ZEMAIRA	alpha-1-proteinase inhibitor (human)	For Injection	125078	16-Apr-19	⤷ Start Trial	2035-05-14
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,083,758

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
United States of America	2015328264	⤷ Start Trial
United States of America	2021330714	⤷ Start Trial
United States of America	2025262250	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.